ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $172,319 | -31.5% | 85,306 | 0.0% | 0.02% | -24.0% |
| Q2 2023 | $251,653 | +18.0% | 85,306 | 0.0% | 0.02% | +8.7% |
| Q1 2023 | $213,265 | -90.3% | 85,306 | -87.8% | 0.02% | -91.5% |
| Q4 2022 | $2,208,314 | +6.1% | 696,629 | -0.6% | 0.27% | -0.4% |
| Q3 2022 | $2,082,000 | -2.6% | 700,926 | 0.0% | 0.27% | +3.0% |
| Q2 2022 | $2,138,000 | -79.2% | 700,926 | -8.0% | 0.26% | -79.1% |
| Q1 2022 | $10,281,000 | +3.6% | 761,563 | 0.0% | 1.26% | +6.0% |
| Q4 2021 | $9,923,000 | +38.9% | 761,563 | 0.0% | 1.19% | +27.4% |
| Q3 2021 | $7,143,000 | -8.4% | 761,563 | 0.0% | 0.94% | -11.4% |
| Q2 2021 | $7,798,000 | – | 761,563 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
| VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
| ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
| Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
| Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
| Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
| DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
| PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
| Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
| RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |